NTRA logo

Natera Inc (NTRA)

Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal...

NASDAQHealthcareDiagnostics & ResearchUSA

Company Profile

Stock Code
NTRA
ISIN Code
US6323071042
Currency
US Dollar (USD)
IPO Date
2015-07-02

Contact Information

Company Address
13011 McCallen Pass, Austin, TX, United States, 78753
Contact Phone
650 980 9190
Company Website
https://www.natera.com
Fiscal Year End
December

Financial Highlights

Market Capitalization
$999,999.99
Gross Profit (TTM)
$999,999.99
Return on Assets (TTM)
-8.08%
EBITDA
$-999,999.99
Revenue (TTM)
$999,999.99